[1]ZHU N，ZHANG D Y，WANG W L，et al．A novel coronavirus from patients with pneumonia in China，2019[J].N engl j med，2020,382(8): 727-733．[2]国家卫生健康委员会.新型冠状病毒感染的肺炎防控方案（第二版）[EB/OL]. [2020-4-29].http//www.nhc. gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.shtml.[3]国家卫生健康委公告 2022 年第 7 号[EB/OL]. [2022-12-26].http://www.gov.cn/zhengce/zhengceku/2022-12/26/content_5733669.htm.[4]Sud A, Torr B, Jones ME, et al.Effect of delays in the 2--week--wait cancer referral pathway during the COVID--19 pandemic on cancer survival in the UK: a mod-elling study[J]. Lancet Oncol. 2020;21(8):1035-44.[5]Nalbandian, A., Sehgal, K., Gupta, A.,et al. Post-acute COVID-19 syndrome[J].Nature Medicine, 27(4), 601–615.[6]2019 冠状病毒病（COVID-19）：COVID-19 长期影响[EB/OL].[2021-12-16].https://www.who.int/zh/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-post-covid-19-condition.[7]Boscolo-Rizzo, P., Guida, F., Polesel, J., et al. (2021). Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19)[J]. International Forum of Allergy & Rhinology, 11(12), 1685–1688.[8]Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact[J]. EClinicalMedicine. 2021;38:101019.[9]Kanmaniraja D, Kurian J, Holder J, et al. Review of COVID 19,part1:abdominal manifestations in adults and multisysteminflammatory syndrome in children[J].Clin Imaging, 2021,80:88-110.[10]Phetsouphanh.C,.Darley.D,.Wilson.DB,.et.al..Immunological.dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection[J]. medRxiv. 2021.Google Scholar[11]arrillo-LarcoRM,Altez-FernandezC,RavagliaS, et al.COVID-19 and Guillain-Barre Syndrome:a systematic review of Case reports[J].Wellcome Open Res,2020,5:107.[12]Dweck MR,BulargaA,HahnRT,etal.Global evaluation of echocardio graphy in patients with COVID-19[J].Eur HeartJCardiovas cImaging,2020,21(9):949-958.[13]Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies[J]. Clin Med (Lond). 2021;21(1):e63-e67.[14]Taku Harada, Kathryn Schmitz, Charles W. Helsper, et al. Long-COVID and long-term cancer survivorship—Shared lessons and opportunities[J].[15]Graham, E. L., Clark , et al.(2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers.”[J]. Annals of Clinical Translational Neurology, 8(5), 1073–1085.[16]de Boer, A. G., Torp, S., Popa, A. et al. (2020). Long-term work retention after treatment for cancer: A systematic review and meta-analysis[J].Journal of Cancer Survivorship, 14(2), 135–150.[17]Heather D'Adamo MD, Thomas Yoshikawa MD, Joseph G. Ouslander MD. Long-COVID and long-term cancer survivorship—Shared lessons and opportunities[J].European Journal of Cancer Care. 2022;31:e13712.[18]BRAMANTE C T, HULING J D, TIGNANELLI C J, et al. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 [J]. New England Journal of Medicine, 2022, 387(7): 599-610.[19]国家卫生健康委办公厅关于印发新冠肺炎出院患者健康管理方案（试行）的通知[EB/0L].[2020-3-13]. http://www.nhc.gov.cn/yzygj/s7653pd/202003/056b2ce9e13142e6a70ec08ef970f1e8.shtml.[20]Manoj Sivan, Amy Parkin, Sophie Makower, et al. Greenwood. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service [J].Journal of Medical Virology.2022,4(94): 1419-1427.[21]Merino, J., Joshi, A. D., Nguyen, L. H., et al.(2021). Diet quality and risk and severity of COVID-19: A prospective cohort study[J]. Gut, 70(11), 2096–2104.[22]Davis, H. E., Assaf, G. S., McCorkell, L., et al. (2021). Characterizing longCOVID in an international cohort: 7 months of symptoms and theirimpact[J]. EClinicalMedicine, 38, 101019.[23]温敏,石义容,苗琪琪,等. 深圳市新型冠状病毒感染患者护理规范[J]. 深圳中西医结合杂志,2022,6(32):5-10.
